TipRanks
Go Ultimate55% OFF

Supernus Pharmaceuticals (0LB2) Balance Sheet

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q3 2026 were $1.40B, a decrease of 2.13% from the previous quarter. GB:0LB2 total liabilities were $335.21M for the fiscal quarter, a 15.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.45B$ 1.37B$ 1.28B$ 1.70B$ 1.69B
$ 390.93M$ 332.34M$ 356.16M$ 816.30M$ 873.30M
$ 1.06B$ 1.04B$ 921.52M$ 886.20M$ 815.85M

Currency in USD

Supernus Pharmaceuticals Debt to Assets

0600M1.2B1.8B15 %30 %45 %60 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets